The immune checkpoint inhibitors market is primarily driven by the increasing prevalence of cancer, rising investment in ...

As the interplay between export controls, trade sanctions, and anticorruption enforcement continues to intensify, ...

Qdenga®, which is undergoing further global registrations, is expected to face competition in the PAHO region from Instituto ...

Masimo said on Wednesday that Joe Kiani has decided to resign as CEO, days after shareholders voted to remove him from the company's board.

Merck said on Wednesday its therapy did not meet the main goal of a late-stage trial evaluating it in patients with a type of ...

The global gynecology drugs market was valued at approximately USD 66.44 billion in 2023 and is projected to experience a healthy compound annual growth rate (CAGR) of 4.8% from 2024 to 2032, reaching ...

The Global Recombinant Proteins Market is valued at approximately USD 2.20 billion in 2023 and is anticipated to grow with a healthy growth rate of more than 12.00% over the forecast period 2024-2032.

PRNewswire/ -- "According to the latest BCC Research study, the demand for "Cell Therapy Biomanufacturing: Global Markets" is ...

First signs of clinical benefit in adjuvant head and neck cancer reported at AACR 2024, paved the way for the start of Phase II part of randomized Phase I/II clinical trial in Q2 2024 – Median ...